You are here

  • Home
  • Archive
  • Volume 14, Issue 4
  • Rofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatmentRofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatment

Citation Tools

Article menu
Download PDFPDF
Therapeutics
Rofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Chan FKL
Rofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatment
BMJ Evidence-Based Medicine 2009;14:111.